Enhertu improved PFS in HER2-low and ultralow
29 April 2024
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one…
£68,092
-49,61%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
…
AstraZeneca: A Triple Shot Of Income, Growth, And Value
…
BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more
Markets Defused aims to present an easy-to-understand and straightforward recap of the week’s most engaging stock market news BHP takeover approach…
Pharma Stock Roundup: MRK, SNY, AZN, NVS Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.…